These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 23801011

  • 1. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.
    Celik O, Celik E, Yilmaz E, Celik N, Turkcuoglu I, Ulas M, Kumbak B, Aktan E, Ozerol I.
    Arch Gynecol Obstet; 2013 Dec; 288(6):1417-22. PubMed ID: 23801011
    [Abstract] [Full Text] [Related]

  • 2. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [Abstract] [Full Text] [Related]

  • 3. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes.
    Liu XH, Wu XH, Yang S.
    Arch Gynecol Obstet; 2019 Dec; 300(6):1773-1783. PubMed ID: 31631249
    [Abstract] [Full Text] [Related]

  • 4. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F, Cobellis L, Mele D, Tassou A, Badolati B, Sorrentino S, De Lucia D, Colacurci N.
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [Abstract] [Full Text] [Related]

  • 5. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
    Choi YS, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
    [Abstract] [Full Text] [Related]

  • 6. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.
    Liu N, Ma Y, Li R, Jin H, Li M, Huang X, Feng HL, Qiao J.
    Endocrine; 2012 Dec; 42(3):708-16. PubMed ID: 22678853
    [Abstract] [Full Text] [Related]

  • 7. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 9. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B, Aslan Cetin B, Vardagli D, Zengin E, Sofiyeva N, Irez T, Ocal P.
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [Abstract] [Full Text] [Related]

  • 10. Serum Stem Cell Factor Assay in Elderly Poor Responder Patients Undergoing IVF: A New Biomarker to Customize Follicle Aspiration Cycle by Cycle.
    Gizzo S, Quaranta M, Andrisani A, Bordin L, Vitagliano A, Esposito F, Venturella R, Zicchina C, Gangemi M, Noventa M.
    Reprod Sci; 2016 Jan; 23(1):61-8. PubMed ID: 26156851
    [Abstract] [Full Text] [Related]

  • 11. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
    Orvieto R, Meltcer S, Homburg R, Nahum R, Rabinson J, Ashkenazi J.
    Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558
    [Abstract] [Full Text] [Related]

  • 12. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP, Macklon NS, Fauser BC.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [Abstract] [Full Text] [Related]

  • 13. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 14. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 15. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [Abstract] [Full Text] [Related]

  • 16. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [Abstract] [Full Text] [Related]

  • 17. E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.
    Siristatidis C, Askoxylaki M, Varounis C, Kassanos D, Chrelias C.
    J Assist Reprod Genet; 2015 Jun; 32(6):959-67. PubMed ID: 25925352
    [Abstract] [Full Text] [Related]

  • 18. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.
    Yang J, Zhang X, Ding X, Wang Y, Huang G, Ye H.
    Reprod Biol Endocrinol; 2021 Aug 12; 19(1):124. PubMed ID: 34384445
    [Abstract] [Full Text] [Related]

  • 19. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE, Beall SA, Cox JM, Richter KS, DeCherney AH, Levy MJ.
    Fertil Steril; 2016 Oct 12; 106(5):1093-1100.e3. PubMed ID: 27341988
    [Abstract] [Full Text] [Related]

  • 20. Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
    Kaya A, Atabekoglu CS, Kahraman K, Taskin S, Ozmen B, Berker B, Sonmezer M.
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct 12; 164(2):167-71. PubMed ID: 22776750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.